Gallenssen Remedies Private Limited - Company Profile

It is a trading private limited company based in Srinagar, Jammu & Kashmir, India, established in 2022.
2022 Srinagar, Jammu & Kashmir, India Active
Last Updated:
Access Report
About Gallenssen Remedies Private Limited

Gallenssen Remedies Private Limited, a active private limited company, was established on 29 August 2022 in Srinagar, Jammu & Kashmir, India. Engaging in specialty within the trading sector, it holds CIN: U51909JK2022PTC013761. Registered under ROC Roc Jammu. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Shahnawaz Aziz (Managing Director), Aashiq Hussain Sofi (Director). Past directors included Zulfkar Waseem. It is based at C/O Shahnawaz Aziz Saki Dafar Chowk Safakadal, Srinagar, Jammu & Kashmir, 191202.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909JK2022PTC013761

  • Registration Number

    013761

  • Incorporation Date

    29 August 2022

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Jammu

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 5 Months
Company report

Gallenssen Remedies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gallenssen Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gallenssen Remedies Private Limited?
Current Directors
Name Designation Appointment Date Status
Shahnawaz Aziz Managing Director 29 Aug 2022 Current
Aashiq Hussain Sofi Director 29 Aug 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Nov 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gallenssen Remedies.

Enhance accessibility to Gallenssen Remedies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Gallenssen Remedies revenue growth over time
Gallenssen Remedies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gallenssen Remedies?

Unlock access to Gallenssen Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gallenssen Remedies?

Gallenssen Remedies has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gallenssen Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gallenssen Remedies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gallenssen Remedies
Recent Activity within the Organization
  • Director Appointment

    Progress on Shahnawaz Aziz was appointed as a Managing Director was appointed as a Managing Director on 29 Aug 2022 & has been associated with this company since 3 years 5 months . was documented.

  • Director Appointment

    Progress on Aashiq Hussain Sofi was appointed as a Director was appointed as a Director on 29 Aug 2022 & has been associated with this company since 3 years 5 months . was documented.

  • Company Incorporation

    Gallenssen Remedies Private Limited was registered on 29 Aug 2022 with Roc Jammu & aged 3 years 5 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gallenssen Remedies Private Limited?

The CIN of Gallenssen Remedies Private Limited is U51909JK2022PTC013761.

Where is Gallenssen Remedies Private Limited headquartered?

Gallenssen Remedies Private Limited is headquartered at C/O Shahnawaz Aziz Saki Dafar Chowk Safakadal, Srinagar, Jammu & Kashmir, 191202.

When was Gallenssen Remedies Private Limited incorporated?

Gallenssen Remedies Private Limited was incorporated on 29 August 2022.

Who are the current directors of Gallenssen Remedies Private Limited?

The current directors of Gallenssen Remedies Private Limited are

What is the primary industry of Gallenssen Remedies Private Limited?

The primary industry of Gallenssen Remedies Private Limited is Trading.

Is Gallenssen Remedies Private Limited a listed company?

Gallenssen Remedies Private Limited is unlisted.

What is the capital structure of Gallenssen Remedies Private Limited?

The authorized capital of Gallenssen Remedies Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Gallenssen Remedies Private Limited?

The compliance status of Gallenssen Remedies Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available